Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
twitter

MetaCyc Enzyme: 3α-hydroxysteroid dehydrogenase (A-specific)

Gene: Akr1c9 Accession Number: G-10914 (MetaCyc)

Species: Rattus norvegicus

Summary:
This enzyme is a member of the aldo-keto reductase family. The human ortholog of the gene encoding this enzyme is AKR1C4 (reviewed in [Russell03]). The rat enzyme shares 67% amino acid sequence identity with the four human isoforms of this enzyme (in [Penning04]).

The native enzyme has been purified from rat liver [Penning84, Usui86] and the recombinant enzyme has been overexpressed in Escherichia coli and purified [Pawlowski94]. It has also been expressed in Simian COS7 cells [Usui94]. The recombinant enzyme has been shown to be essentially identical in properties to the native enzyme (in [Penning04]).

The crystal structure of the enzyme has been determined [Bennett97, Bennett96, Hoog94].

The apparent molecular mass was determined to be 34 kDa by SDS-PAGE and 33 kDa by gel filtration chromatography [Penning84].
Note that UniProtKB/Swiss-Prot accession P23457 designates this gene as Akr1c9, although it links to Entrez GeneID: 191574 which names the gene Akr1c14.

Gene Citations: [Lin99, Pawlowski91, Stolz91]

Locations: cytosol

Molecular Weight of Polypeptide: 37.028 kD (from nucleotide sequence), 34.0 kD (experimental) [Penning84 ]

pI: 5.8 [Penning84]

Unification Links: Mint:MINT-4567560 , Pride:P23457 , Protein Model Portal:P23457 , SMR:P23457 , String:P23457 , UniProt:P23457

Relationship Links: Entrez-Nucleotide:PART-OF:AF180334 , InterPro:IN-FAMILY:IPR001395 , InterPro:IN-FAMILY:IPR018170 , InterPro:IN-FAMILY:IPR020471 , InterPro:IN-FAMILY:IPR023210 , Panther:IN-FAMILY:PTHR11732 , PDB:Structure:1afs , PDB:Structure:1lwi , PDB:Structure:1ral , Pfam:IN-FAMILY:PF00248 , Prints:IN-FAMILY:PR00069 , Prosite:IN-FAMILY:PS00062 , Prosite:IN-FAMILY:PS00063 , Prosite:IN-FAMILY:PS00798

Gene-Reaction Schematic: ?

GO Terms:

Cellular Component: GO:0005829 - cytosol [Penning84]

Credits:
Created 16-Oct-2008 by Fulcher CA , SRI International


Enzymatic reaction of: NADPH-dehydroascorbate reductase (3α-hydroxysteroid dehydrogenase (A-specific))

L-dehydro-ascorbate + NADPH <=> L-ascorbate + NADP+

The reaction direction shown, that is, A + B ↔ C + D versus C + D ↔ A + B, is in accordance with the direction in which it was curated.

The reaction is favored in the direction shown.

Alternative Substrates for L-dehydro-ascorbate: 5α-androstane-3,17-dione [Del94 ]

In Pathways: ascorbate recycling (cytosolic)

Summary:
This enzyme was purified to homogeneity from rat liver cytosol and was shown to have NADPH-dependent dehydroascorbate reductase activity. This activity was strongly inhibited by steroidal and non-steroidal anti-inflammatory drugs. Its identity with 3α-hydroxysteroid dehydrogenase was confirmed by amino acid sequence analysis of cyanogen bromide fragments [Del94].

Kinetic Parameters:

Substrate
Km (μM)
Citations
NADPH
4.3
[Del94]
L-dehydro-ascorbate
4600.0
[Del94]

pH(opt): 6.2 [Del94]


Enzymatic reaction of: 7α-hydroxy-5β-cholestan-3-one 3α-reductase (3α-hydroxysteroid dehydrogenase (A-specific))

5β-cholestane-3α,7α-diol + NAD(P)+ <=> 7α-hydroxy-5β-cholestan-3-one + NAD(P)H + H+

The reaction direction shown, that is, A + B ↔ C + D versus C + D ↔ A + B, is in accordance with the Enzyme Commission system.

The reaction is favored in the opposite direction.

In Pathways: bile acid biosynthesis, neutral pathway


Enzymatic reaction of: 7α, 12α-dihydroxy-5β-cholestan-3-one 3α-reductase (3α-hydroxysteroid dehydrogenase (A-specific))

Synonyms: 3α-hydroxysteroid:NAD(P)+ oxidoreductase (A-specifid), 3α-hydroxysteroid/dihydrodiol dehydrogenase

5β-cholestane-3α,7α,12α-triol + NAD(P)+ <=> 7α,12α-dihydroxy-5β-cholestan-3-one + NAD(P)H + H+

The reaction direction shown, that is, A + B ↔ C + D versus C + D ↔ A + B, is in accordance with the Enzyme Commission system.

The reaction is favored in the opposite direction.

Alternative Substrates for 7α,12α-dihydroxy-5β-cholestan-3-one: 7α-hydroxy-5β-cholestan-3-one [Usui86 ] , 3-oxo-5β-cholan-24-oate [Usui86 ] , acetophenone [Penning84 ] , duroquinone [Penning84 ] , menadione [Penning84 ] , 4-nitrobenzaldehyde [Penning84 ] , phenanthrenequinone [Penning84 ] , 1,4-benzoquinone [Penning84 ] , 1,4-naphthoquinone [Penning84 ]

In Pathways: bile acid biosynthesis, neutral pathway

Summary:
This enzyme is designated as EC 1.1.1.213, rather than EC 1.1.1.50, because it is an A-specific enzyme that catalyzes the transfer of the 4-pro-R-hydride ion from a nicotinamide cofactor to the carbonyl of an acceptor (in [Penning04a] in [Usui94] and in [Penning04]). Earlier literature used EC 1.1.1.50, which is now designated as a B-specific enzyme. B-specific enzymes catalyze the transfer of the 4-pro-S-hydride ion.

This reaction is the last step in sterol ring modification during bile acid biosynthesis. It is followed by side chain modification reactions. The reaction involves reduction of the 3-keto group to an α-hydroxyl group (reviewed in [Russell03]). The enzyme also functions in steroid hormone and xenobiotic metabolism, although 3α-hydroxysteroids are the most efficient substrates (in [Pawlowski94].

The reduction of 7α,12α-dihydroxy-5β-cholestan-3-one by this enzyme was demonstrated [Usui86].

The enzyme is inhibited by both nonsteroidal and steroidal anti-inflammatory drugs. Inhibition of the reduction of 7α-hydroxy-5β-cholestan-3-one by indomethacin and dexamethasone was demonstrated [Usui86]. The reduction of phenanthrenequinone and oxidation of androsterone was inhibited by arachidonate and various prostaglandins [Penning84]. The enzyme was not inhibited by D-glucuronate, DL-glyceraldehyde, or glycolaldehyde [Usui86].

Both NADPH and NADH could serve as cofactor, although reactions were more efficient with NADPH [Pawlowski94, Usui86]. A pH optimum of 7.4 was determined for the reduction of 7α-hydroxy-5β-cholestan-3-one [Usui86].

The complete kinetic mechanism of this enzyme has been elucidated using 5α-androstane-3,17-dione and NADPH in the reductive direction and androsterone and NADP+ in the oxidative direction [Cooper07].

Inhibitors (Unknown Mechanism): p-chloromercuribenzoate [Usui86]


References

Bennett96: Bennett MJ, Schlegel BP, Jez JM, Penning TM, Lewis M (1996). "Structure of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase complexed with NADP+." Biochemistry 35(33);10702-11. PMID: 8718859

Bennett97: Bennett MJ, Albert RH, Jez JM, Ma H, Penning TM, Lewis M (1997). "Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase." Structure 5(6);799-812. PMID: 9261071

Cooper07: Cooper WC, Jin Y, Penning TM (2007). "Elucidation of a complete kinetic mechanism for a mammalian hydroxysteroid dehydrogenase (HSD) and identification of all enzyme forms on the reaction coordinate: the example of rat liver 3alpha-HSD (AKR1C9)." J Biol Chem 282(46);33484-93. PMID: 17848571

Del94: Del Bello B, Maellaro E, Sugherini L, Santucci A, Comporti M, Casini AF (1994). "Purification of NADPH-dependent dehydroascorbate reductase from rat liver and its identification with 3 alpha-hydroxysteroid dehydrogenase." Biochem J 304 ( Pt 2);385-90. PMID: 7998972

Hoog94: Hoog SS, Pawlowski JE, Alzari PM, Penning TM, Lewis M (1994). "Three-dimensional structure of rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily." Proc Natl Acad Sci U S A 91(7);2517-21. PMID: 8146147

Lin99: Lin HK, Hung CF, Moore M, Penning TM (1999). "Genomic structure of rat 3alpha-hydroxysteroid/dihydrodiol dehydrogenase (3alpha-HSD/DD, AKR1C9)." J Steroid Biochem Mol Biol 71(1-2);29-39. PMID: 10619355

Pawlowski91: Pawlowski JE, Huizinga M, Penning TM (1991). "Cloning and sequencing of the cDNA for rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase." J Biol Chem 266(14);8820-5. PMID: 1840601

Pawlowski94: Pawlowski JE, Penning TM (1994). "Overexpression and mutagenesis of the cDNA for rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase. Role of cysteines and tyrosines in catalysis." J Biol Chem 269(18);13502-10. PMID: 8175784

Penning04: Penning TM, Jin Y, Steckelbroeck S, Lanisnik Rizner T, Lewis M (2004). "Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins." Mol Cell Endocrinol 215(1-2);63-72. PMID: 15026176

Penning04a: Penning TM (2004). "Aldo-keto reductases and formation of polycyclic aromatic hydrocarbon o-quinones." Methods Enzymol 378;31-67. PMID: 15038957

Penning84: Penning TM, Mukharji I, Barrows S, Talalay P (1984). "Purification and properties of a 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs." Biochem J 222(3);601-11. PMID: 6435601

Russell03: Russell DW (2003). "The enzymes, regulation, and genetics of bile acid synthesis." Annu Rev Biochem 72;137-74. PMID: 12543708

Stolz91: Stolz A, Rahimi-Kiani M, Ameis D, Chan E, Ronk M, Shively JE (1991). "Molecular structure of rat hepatic 3 alpha-hydroxysteroid dehydrogenase. A member of the oxidoreductase gene family." J Biol Chem 266(23);15253-7. PMID: 1714456

Usui86: Usui E, Okuda K (1986). "Identification of 7 alpha,12 alpha-dihydroxy-5 beta-cholestan-3-one 3 alpha-hydroxysteroid dehydrogenase." Biochim Biophys Acta 877(1);158-66. PMID: 3459552

Usui94: Usui E, Okuda K, Kato Y, Noshiro M (1994). "Rat hepatic 3 alpha-hydroxysteroid dehydrogenase: expression of cDNA and physiological function in bile acid biosynthetic pathway." J Biochem 115(2);230-7. PMID: 7515872


Report Errors or Provide Feedback
Please cite the following article in publications resulting from the use of MetaCyc: Caspi et al, Nucleic Acids Research 42:D459-D471 2014
Page generated by SRI International Pathway Tools version 18.5 on Thu Dec 18, 2014, BIOCYC13A.